In this article, we will discuss Selumetinib (Dosage Overview). So, let’s get started.


Selumetinib is indicated for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).


Recommended Dosage

The recommended dosage of Selumetinib is 25 mg/m² orally twice daily (approximately every 12 hours) until disease progression or unacceptable toxicity.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.